These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9684793)

  • 1. Control of oral anticoagulation in patients with the antiphospholipid syndrome--influence of the lupus anticoagulant on International Normalized Ratio. Groupe Méthodologie en Hémostase du Groupe d'Etudes sur l'Hémostases et la Thrombose.
    Robert A; Le Querrec A; Delahousse B; Caron C; Houbouyan L; Boutière B; Horellou MH; Reber G; Sié P
    Thromb Haemost; 1998 Jul; 80(1):99-103. PubMed ID: 9684793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
    Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential failure of the International Normalized Ratio (INR) System in the monitoring of oral anticoagulation in patients with lupus anticoagulants.
    Della Valle P; Crippa L; Safa O; Tomassini L; Pattarini E; Vigano-D'Angelo S; Grazia Sabbadini M; D'Angelo A
    Ann Med Interne (Paris); 1996 Sep; 147 Suppl 1():10-4. PubMed ID: 8952752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
    Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
    Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins.
    Tripodi A; Chantarangkul V; Clerici M; Negri B; Galli M; Mannucci PM
    Br J Haematol; 2001 Dec; 115(3):672-8. PubMed ID: 11736953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of sensitivity and specificity of a standardized procedure using different reagents for the detection of lupus anticoagulants. The Working Group on Hemostasis of the Société Française de Biologie Clinique and for the Groupe d'Etudes sur I'Hémostase et la Thrombose.
    Goudemand J; Caron C; De Prost D; Derlon A; Borg JY; Sampol J; Sié P
    Thromb Haemost; 1997 Feb; 77(2):336-42. PubMed ID: 9157593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point-of-care testing of the international normalized ratio in patients with antiphospholipid antibodies.
    Perry SL; Samsa GP; Ortel TL
    Thromb Haemost; 2005 Dec; 94(6):1196-202. PubMed ID: 16411394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Warfarin monitoring in antiphospholipid syndrome and lupus anticoagulant.
    Crowl A; Schullo-Feulner A; Moon JY
    Ann Pharmacother; 2014 Nov; 48(11):1479-83. PubMed ID: 25104566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral anticoagulant therapy and international normalized ratios in swine.
    McGlasson DL; Brickey DA; Doe RH
    Lab Anim Sci; 1998 Aug; 48(4):371-3. PubMed ID: 10090045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The factors that influence the consistency of international normalized ratio of prothrombin time].
    Su W; Ren FQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Apr; 23(2):196-8. PubMed ID: 12905903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of EDTA samples for prothrombin time measurement in patients receiving oral anticoagulants.
    Horsti J
    Haematologica; 2001 Aug; 86(8):851-5. PubMed ID: 11522542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent venous thrombosis despite 'optimal anticoagulation therapy' for antiphospholipid syndrome--could new oral anticoagulants solve the problem?
    Balaban M; Stanrić V; Rincić G; Ledinsky M; Grbac L; Stancić N; Tomasić H
    Acta Clin Croat; 2010 Dec; 49(4):469-77. PubMed ID: 21830460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unreliability of international normalized ratio for monitoring warfarin therapy in patients with lupus anticoagulant.
    Rosborough TK; Shepherd MF
    Pharmacotherapy; 2004 Jul; 24(7):838-42. PubMed ID: 15303447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardization of lupus anticoagulant. Feasibility study of a calibration model to minimize between-method variability.
    Tripodi A; Chantarangkul V; Clerici M; Palmucci C; Bison E; Banzato A; Biguzzi E; Pengo V
    Thromb Res; 2011 Jun; 127(6):589-94. PubMed ID: 21356545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inter-institute variations in International Normalized Ratio and thrombotest].
    Nozawa T; Hayashi S; Naiki S; Niiya K; Asanoi H; Inoue H
    J Cardiol; 1998 Aug; 32(2):89-94. PubMed ID: 9752617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring anticoagulant therapy with vitamin K antagonists in patients with antiphospholipid syndrome.
    Isert M; Miesbach W; Schüttfort G; Weil Y; Tirneci V; Kasper A; Weber A; Lindhoff-Last E; Herrmann E; Linnemann B
    Ann Hematol; 2015 Aug; 94(8):1291-9. PubMed ID: 25859986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).
    Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P
    Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of oral anticoagulant therapy in lupus anticoagulant positive patients with the anti-phospholipid syndrome.
    Lawrie AS; Purdy G; Mackie IJ; Machin SJ
    Br J Haematol; 1997 Sep; 98(4):887-92. PubMed ID: 9326184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality assurance program for whole blood prothrombin time-international normalized ratio point-of-care monitors used for patient self-testing to control oral anticoagulation.
    Tripodi A; Bressi C; Carpenedo M; Chantarangkul V; Clerici M; Mannucci PM
    Thromb Res; 2004; 113(1):35-40. PubMed ID: 15081563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.